Sign inGet started

Ray Amrit

Insider CIK 1924797 · RARE Director · FTRE Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
FTRE Fortrea Holdings Inc. M Exercise deriv2026-06-102026-06-1238,817— $00SEC↗
FTRE Fortrea Holdings Inc. A Award deriv2026-06-102026-06-1212,852— $012,852SEC↗
FTRE Fortrea Holdings Inc. M Exercise2026-06-102026-06-1238,817— $052,453SEC↗
RARE Ultragenyx Pharmaceutical A Award deriv2026-05-142026-05-1814,058— $014,058SEC↗
RARE Ultragenyx Pharmaceutical A Award2026-05-142026-05-187,751— $031,116SEC↗
FTRE Fortrea Holdings Inc. A Award deriv2025-06-102025-06-1238,817— $038,817SEC↗
RARE Ultragenyx Pharmaceutical A Award deriv2025-05-152025-05-1910,787— $010,787SEC↗
RARE Ultragenyx Pharmaceutical A Award2025-05-152025-05-195,740— $023,365SEC↗
FTRE Fortrea Holdings Inc. M Exercise deriv2025-05-142025-05-167,282— $00SEC↗
FTRE Fortrea Holdings Inc. M Exercise2025-05-142025-05-167,282— $013,636SEC↗
FTRE Fortrea Holdings Inc. M Exercise deriv2024-07-182024-07-196,354— $07,282SEC↗
FTRE Fortrea Holdings Inc. M Exercise2024-07-182024-07-196,354— $06,354SEC↗
RARE Ultragenyx Pharmaceutical A Award deriv2024-06-182024-06-209,900— $09,900SEC↗
RARE Ultragenyx Pharmaceutical A Award2024-06-182024-06-205,345— $017,625SEC↗
FTRE Fortrea Holdings Inc. A Award deriv2024-05-142024-05-167,282— $013,636SEC↗
FTRE Fortrea Holdings Inc. A Award deriv2023-07-182023-07-196,354— $06,354SEC↗
RARE Ultragenyx Pharmaceutical A Award deriv2023-06-072023-06-097,110— $07,110SEC↗
RARE Ultragenyx Pharmaceutical A Award2023-06-072023-06-093,860— $012,280SEC↗
RARE Ultragenyx Pharmaceutical A Award deriv2022-06-242022-06-286,245— $06,245SEC↗
RARE Ultragenyx Pharmaceutical A Award2022-06-242022-06-283,300— $08,420SEC↗
RARE Ultragenyx Pharmaceutical A Award deriv2022-04-192022-04-229,525— $09,525SEC↗
RARE Ultragenyx Pharmaceutical A Award2022-04-192022-04-225,120— $05,120SEC↗